Dietary treatment in adults with refractory epilepsy
A review
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 12, 2014
- Accepted in final form August 20, 2014
- First Published October 29, 2014.
Article Versions
- Previous version (October 29, 2014 - 13:01).
- You are viewing the most recent version of this article.
Author Disclosures
- Pavel Klein, MBBChir,
- Ivana Tyrlikova, MD and
- Gregory C. Mathews, MD, PhD
- Pavel Klein, MBBChir,
Accorda,Inc: advisory board Eisai: advisory board UC Davis: DSMB, UC Davis Allopregnanolone TBI Clinical Trial (no compensation received to-date)
NONE
Speaker's bureau: UCB Pharma, Inc; Glaxo Smith Kline, travel expenses related to speaking Cyberonics: travel to a company-sponsored meeting
NONE
U.S. Patent Application No. 62/024,827 �KETOGENIC FOOD COMPOSITIONS AND USES THEREOF� Applicant: OH! MBF Reference No.: 207953-9003-US00 Application No. 62/024,827 The application was filed on July 15, 2014 (after the submission of the final revision of the present manuscript).The patent application is for use of ketogenic foods for various madical conditions.
NONE
Self-employed
NONE
Speaker's bureau: UCB Pharma, Inc; Glaxo Smith Kline; Eisai; Sunovion
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ivana Tyrlikova, MD and
NONE
NONE
NONE
NONE
NONE
NONE
1) Mid-Atlantic Epilepsy and Sleep Center,Clinical Research Associate, 1.5 year
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gregory C. Mathews, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence to Dr. Klein: kleinp{at}epilepsydc.com
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticusMackenzie C. Cervenka, Sara Hocker, Matthew Koenig et al.Neurology, February 08, 2017 -
Article
Ketogenic diet for adults in super-refractory status epilepticusKiran T. Thakur, John C. Probasco, Sara E. Hocker et al.Neurology, January 22, 2014 -
Brief Communications
Efficacy of the Atkins diet as therapy for intractable epilepsyEric H. Kossoff, Gregory L. Krauss, Jane R. McGrogan et al.Neurology, December 22, 2003 -
Brief Communications
Low-glycemic-index treatment: A liberalized ketogenic diet for treatment of intractable epilepsyHeidi H. Pfeifer, Elizabeth A. Thiele et al.Neurology, December 12, 2005